Pharmaniaga Berhad

KLSE:PHARMA 주식 보고서

시가총액: RM 511.6m

Pharmaniaga Berhad 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Zulkifli Bin Jafar

최고 경영자

RM 168.6k

총 보상

CEO 급여 비율83.1%
CEO 임기less than a year
CEO 소유권n/a
경영진 평균 재임 기간1.3yrs
이사회 평균 재임 기간2.5yrs

최근 관리 업데이트

Recent updates

Pharmaniaga Berhad's (KLSE:PHARMA) Shares Bounce 25% But Its Business Still Trails The Industry

Jul 18
Pharmaniaga Berhad's (KLSE:PHARMA) Shares Bounce 25% But Its Business Still Trails The Industry

Why Investors Shouldn't Be Surprised By Pharmaniaga Berhad's (KLSE:PHARMA) Low P/S

May 09
Why Investors Shouldn't Be Surprised By Pharmaniaga Berhad's (KLSE:PHARMA) Low P/S

Pharmaniaga Berhad (KLSE:PHARMA) Shares Could Be 49% Below Their Intrinsic Value Estimate

Apr 19
Pharmaniaga Berhad (KLSE:PHARMA) Shares Could Be 49% Below Their Intrinsic Value Estimate

Insufficient Growth At Pharmaniaga Berhad (KLSE:PHARMA) Hampers Share Price

Oct 03
Insufficient Growth At Pharmaniaga Berhad (KLSE:PHARMA) Hampers Share Price

Is There An Opportunity With Pharmaniaga Berhad's (KLSE:PHARMA) 37% Undervaluation?

Jul 19
Is There An Opportunity With Pharmaniaga Berhad's (KLSE:PHARMA) 37% Undervaluation?

Is It Too Late To Consider Buying Pharmaniaga Berhad (KLSE:PHARMA)?

Feb 18
Is It Too Late To Consider Buying Pharmaniaga Berhad (KLSE:PHARMA)?

Many Would Be Envious Of Pharmaniaga Berhad's (KLSE:PHARMA) Excellent Returns On Capital

Dec 10
Many Would Be Envious Of Pharmaniaga Berhad's (KLSE:PHARMA) Excellent Returns On Capital

Bullish: Analysts Just Made A Massive Upgrade To Their Pharmaniaga Berhad (KLSE:PHARMA) Forecasts

Nov 24
Bullish: Analysts Just Made A Massive Upgrade To Their Pharmaniaga Berhad (KLSE:PHARMA) Forecasts

We Think That There Are Issues Underlying Pharmaniaga Berhad's (KLSE:PHARMA) Earnings

Aug 27
We Think That There Are Issues Underlying Pharmaniaga Berhad's (KLSE:PHARMA) Earnings

Pharmaniaga Berhad (KLSE:PHARMA) Has A Somewhat Strained Balance Sheet

May 28
Pharmaniaga Berhad (KLSE:PHARMA) Has A Somewhat Strained Balance Sheet

CEO 보상 분석

Zulkifli Bin Jafar 의 보수는 Pharmaniaga Berhad 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2024n/an/a

-RM 56m

Mar 31 2024n/an/a

-RM 57m

Dec 31 2023RM 169kRM 140k

-RM 80m

Sep 30 2023n/an/a

-RM 667m

Jun 30 2023n/an/a

-RM 654m

Mar 31 2023n/an/a

-RM 655m

Dec 31 2022RM 1mRM 800k

-RM 630m

Sep 30 2022n/an/a

RM 100m

Jun 30 2022n/an/a

RM 164m

Mar 31 2022n/an/a

RM 177m

Dec 31 2021RM 145kn/a

RM 172m

Sep 30 2021n/an/a

RM 80m

Jun 30 2021n/an/a

RM 32m

Mar 31 2021n/an/a

RM 28m

Dec 31 2020RM 61kn/a

RM 27m

보상 대 시장: Zulkifli 의 총 보상 ($USD 37.85K ) MY 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 108.01K ).

보상과 수익: Zulkifli 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Zulkifli Bin Jafar (52 yo)

less than a year

테뉴어

RM 168,569

보상

Encik Zulkifli Bin Jafar is the Managing Director at Pharmaniaga Berhad since September 1, 2024 and serves as its Deputy Chief Executive Officer since February 22, 2023 and was its Executive Director since...

리더십 팀

이름위치테뉴어보상소유권
Zulkifli Bin Jafar
Deputy CEO & Managing Directorless than a yearRM 168.57k데이터 없음
Norai'ni Binti Mohamed Ali
Chief Financial Officer12.4yrs데이터 없음데이터 없음
Ahmad Shahredzuan Mohd Shariff
COO & Directorless than a yearRM 136.05k데이터 없음
Badarulhisam Rahman
Chief Scientific Officer1.8yrs데이터 없음데이터 없음
Abdul Mohamed
Executive Vice President of Logistics & Distribution Divisionno data데이터 없음데이터 없음
Zulhazri bin Razali
Executive Vice President of Commercial Divisionno data데이터 없음데이터 없음
Wan Intan Wan Ismail
Executive VP of Corporate Governance & Company Secretary5yrs데이터 없음데이터 없음
Azni Basri
Chief People Officerless than a year데이터 없음데이터 없음
Idham Ismail
Chief Strategy Officerno data데이터 없음데이터 없음
Mohd Ishak
Acting Head of Manufacturing Operationsless than a year데이터 없음데이터 없음
Fazleena Jasin
Head of Sustainabilityno data데이터 없음데이터 없음
Syaruzaimi Yusof
Company Secretary5yrs데이터 없음데이터 없음

1.3yrs

평균 재임 기간

54yo

평균 연령

경험이 풍부한 관리: PHARMA 의 관리팀은 경험 (평균 재직 기간 1.3 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.

이사회 구성원

이름위치테뉴어보상소유권
Zulkifli Bin Jafar
Deputy CEO & Managing Directorless than a yearRM 168.57k데이터 없음
Ahmad Shahredzuan Mohd Shariff
COO & Director1.8yrsRM 136.05k데이터 없음
Ahmad Bakar
President Director of PT Millennium Pharmacon International Tbk4.3yrs데이터 없음데이터 없음
Yves Champey
Member of Board Advisory Panelno data데이터 없음데이터 없음
Izaddeen Bin Daud
Non-Independent Director3.7yrsRM 192.81k데이터 없음
Mohd Bin Zahur Hussain
Independent Non Executive Directorless than a yearRM 40.00k데이터 없음
V. Navaratnam
Member of Board Advisory Panelno data데이터 없음데이터 없음
Musa bin Mohamad
Chairman of Board Advisory Panelno data데이터 없음데이터 없음
Piero Olliaro
Member of Board Advisory Panelno data데이터 없음데이터 없음
Sarah binti Abdul Samat
Independent & Non-Executive Director3.3yrsRM 181.67k데이터 없음
Abdul Bin Jaafar
Independent Non Executive Chairmanless than a year데이터 없음데이터 없음
Abdul Bin Ahmad
Senior Independent & Non-Executive Director4yrsRM 190.04k데이터 없음

2.5yrs

평균 재임 기간

52yo

평균 연령

경험이 풍부한 이사회: PHARMA 의 이사회는 경험(평균 재직 기간 2.5 년)으로 간주되지 않으므로 새 이사회가 필요합니다.